GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] we are measuring MASH at the wrong time and calling it noise — 27 comments in the full submission. View in context.
303
c/survodutide·submitted 11 months ago by u/rania_salinas

[Discussion] we are measuring MASH at the wrong time and calling it noise

Discussionbranch of 5 comments

Trying to settle this properly because the thread from last year went in circles. The claim: MASH matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 22 months without either producing anything. What would actually settle it is 5 people measuring the same thing…

Read the full submission and all 27 comments →

This branch

5 comments, started 11 months ago
u/julia_mensa36 points·11 months ago

Every time this gets posted it hits the front page and every time someone has to re-explain it.

replysharereportpermalink
[removed]13 points·11 months ago

[removed by moderator]

replysharereportpermalink
u/trialwatch_theoMOD26 points·10 months ago

Retitled to remove editorialising. Put the evidence in the body.

replysharereportpermalink
u/neha_rahimi14 points·10 months ago

Which trial arm?

replysharereportpermalink
u/santiago_villalobos4 points·10 months ago

That is net peptide content, not purity. Different number, different meaning.

replysharereportpermalink

← back to the whole thread

About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.